Statistics

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	46

	Downloads
6807-30551.pdf	67

Select a period of time:

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	28

	Downloads
6807-30551.pdf	3

	Downloads
United States	1

	Downloads

RUNA digital repository